key: cord-0838220-zlpyw4l4 authors: Pramanik, S.; Karmakar, S.; Mukherjee, S.; Dhavale, I.; Shrestha, R. title: Unmasking the Current Scenario of Indian Biomedical Devices Industry: Ventilators being the Heart of the Discussion date: 2021-03-02 journal: nan DOI: 10.1101/2021.02.26.21251720 sha: 47365525e4f7ae41086ef5f8fc4c84574479a93f doc_id: 838220 cord_uid: zlpyw4l4 Background The Indian Biomedical Device Industry has been growing at an unprecedented rate, but several hindrances need to be acknowledged in offering access to quality, budget-friendly medical devices in India. This article explores the current loopholes of the Indian biomedical device industry along with the proposal of various innovative solutions, with emphasis on ventilators. Methods An online survey with the help of Google forms was conducted from 1st November to 25th December 2020, addressing the problems of the Indian medical device industry (MDI) along with probable solutions. The survey also provides a glimpse into the complications aroused from the frequent use of ventilators during COVID-19 outburst, along with possible measures. Results According to the survey, 51.6%, 46.5%, 55.7%, and 47.5% of respondents have agreed to 'Stringent laws and implementation,' 'Safety testing and strict regulations,' 'Unfavorable duty structure,' and 'Reducing tax rate on domestic manufacturers,' as a possible solution to advance the implementation of ISO 13485 and ISO 10651, implementation of ISO 14971, the probable cause of limitations of Indian MDI, possible measure to overcome limitations of Indian MDI, respectively. 46.7%, 47.5%, 46.2%, and 44.6% of respondents have agreed to 'Surgical decompression,' 'Nebulized and broad-spectrum antibiotics,' 'PEEP,' and 'Adopting lung protective ventilation strategies' as possible solutions to treat various ventilator complications, respectively. Conclusion The study briefs about the people's perception of the Indian MDI as well as on the ventilator complications. The results complied with our hypothesis as the majority of the respondents have agreed with almost all the probable solutions in both the sections given by us as options. In the wake of COVID 19, we have had many implications, some positive and some negative. As they say, necessity is the mother of invention, and only upon seeing the impact of the pandemic have we as a nation began to understand the importance of Pharmacy and Biomedical Sciences in minimizing the negative impacts and creating long-lasting positive changes for generations to come. The "Make in India" initiative started way back in 2014 by Prime Minister Narendra Modi, paved the way for the "Self Reliant Movement" ( Aatmanirbhar Bharat Abhiyaan) in 2020 amidst the coronavirus pandemic [1] . We now see the importance and the need to be free, a type of second independence, to be independent as a nation in our production of biomedical supplies and devices. At present, around 75-80% is India's overall import dependency, which is quite surprising when considering India to be among the top-20 markets for medical devices globally. The current scenario in terms of the market size in India is estimated at 11 billion dollars. This figure is expected to go up to 50 billion dollars by 2025. According to the statistics of the year 2018- 19, imports have been valued at 6.2 billion dollars, whereas the exports have been a meager $2.1 billion. India's expected export of medical devices will reach an estimated $10 billion by 2025 [2] . Upon inspection, it is seen that the biomedical sector in India is far from perfect. There are numerous limitations we need to face and work on. India has a long way too, but just as India is a rapidly developing nation, its biomedical sector is rapidly improving and evolving. As we look into the limitations, we find various factors responsible primarily in the industry's macro-environment [3] . The sector of the biomedical device is relatively capital intensive, and in the present scenario, the cost of financing is in the range of 14-Ventilator-Associated pneumonia and microaspiration [12] , barotrauma [13] , Acute respiratory distress syndrome (ARDS) [14] . This research survey aims to pinpoint the stumbling blocks prevailing in the Indian biomedical industry, identify the patient's problem caused due to frequent use of mechanical ventilators, and correlate the proposed groundwork solutions for both of the above significant issues with the perspective of the respondents. Survey research is a way to congregate data about a sample drawn from a precisely defined population of persons or organizations. It offers researchers an opportunity to gather useful data, although substitute tools such as remarks, panels, focus communities, and interviews might furnish, at times, excellent information. This study utilized a cross-sectional research questionnaire survey of bio-researchers and medical device industrialists of India. The population (n=315) included the students from the department of pharmacy and biomedical engineering. The respondents holding various degrees participated in the aforementioned research survey. A convenient sampling design was prepared for this study because of the time constraints imposed on the same. For better understanding, the readers are referred to check the survey instrument (see Appendix 1). The data collection tool was first pilot-tested with selected pharma/biomedical students (5-10 people) for better understanding. The final google form questionnaire was then disseminated via different social handles and emails to the targeted communities. The survey started on 1 st Nov 2020. The targeted communities included biomedical engineering, pharmacy students/researchers/industrialists who had a basic knowledge of the research topic. It was suggested that every community of people pass the questionnaire survey to their respected colleagues for a better sample score. A URL of the google form was provided to our targeted population with a specific deadline to complete the survey electronically. In addition to the primary emails, the survey conductors made follow-up emails and messages to complete their filling of the survey. The respondents were provided sufficient time to fill the survey, which closed on 25 th December 2020. All the data provided by the respondents were confidential and were not exposed publically. The people who pre-or pilot-tested the questionnaire survey were ruled out from study contribution. IBM SPSS Statistics Version 26.0 for Windows (IBM Corp., Armonk, NY, U.S.) was utilized to execute the analyses to address the research-based questions. The Cronbach alpha value for every research-based question was calculated to understand the reliability of the data. The data which were reliable were analyzed further to calculate mean, median, and standard deviations. Descriptive statistics were also provided for each of the questions of the survey. The categorical data were outlined using frequencies and percentages. The questionnaire was distributed between all pharmacy/biomedical engineering college students and pharma biomedical industrialists to understand the respondents' perception of our proposed solutions for each stumbling problem faced by the Indian biomedical industry. According to Chart 1, 64.13% of respondents fell in the age group of 21-30, followed by 21.59% of respondents in the age group of 31-40. Table 1 depicts the frequency characteristics of the same. Chart 1. The age distribution of the respondents of the questionnaire survey. From Chart 2 and Table 2 , we observed that most of the respondents had Ph. D. (45.40%) as their educational qualification, followed by 29.21% of respondents who were post-graduated. Thus, most of the collected data is based on highly qualified respondents' perceptions, leading to more reliability. The educational qualification statistics of the respondents of the questionnaire survey. Medical device means 'any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings, for one or more of the specific medical purpose(s) of: • diagnosis, prevention, monitoring, treatment, or alleviation of disease, • diagnosis, monitoring, treatment, alleviation of or compensation for an injury, • the investigation, replacement, modification, or support of the anatomy or of a physiological process, • supporting or sustaining life, • control of conception, • disinfection of medical devices • providing information by means of in vitro examination of specimens derived from the human body; and does not achieve its primary intended action by pharmacological, immunological or metabolic means, in or on the human body, but which may be assisted in its intended function by such means [15] . This question was intended to determine whether the respondents were aware of the medical devices and their sectors. the questionnaire. 1.29% of the respondents were unaware, and 2.59% of respondents were confused about the same. Chart 3. The percentage of respondents having knowledge on medical devices. Table 3 denotes the frequency characteristics of the same question calculated from the collected data of the respondents. We also tried to gain an in-depth understanding knowledge of the respondents on common standard medical devices used in the healthcare sector as well as daily life. Have you ever heard of Biomedical Devices? All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. The Indian medical devices industry has a probability of leapfrogging novelty combining physical devices and incorporating digital infrastructure for long-term innovation. Medical devices in India are now deemed to perform an essential role in delivering quality health care to the people. The initiation of MDR 2017 was a substantial breakthrough in the establishment of a powerful platform. The awareness around the need to have a robust medical devices ecosystem in the country is gaining traction resulting in higher growth rates for India as compared to the global industry. The objective was to determine if respondents, mostly from the biomedical fraternity, know any top Indian medical devices manufacturing company. According to Chart 5, 83.2 % of respondents are mostly aware of Indian companies manufacturing medical devices, and 8% of respondents are unsure about the same. Table 4 depicts the frequency characteristics of the same data collected from the respondents. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This question doesn't confirm whether the companies they think to be Indian are Indian companies or not. The next question throws light on that. Do you know any Indian companies who make medical devices? All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also tried to investigate the respondents' awareness about the companies manufacturing medical devices in India. Some multinational companies that made their products popular in India may be considered Indian companies in public perception. Based on the data acquired, depicted in Chart 6 and Fig 2, (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; On this positive note, we look into the several steps the Government of India has taken to ensure the development of a vibrant ecosystem of medical device manufacturing in India over the past few years, such as the ones mentioned previously. These include acts such as The Medical Devices Amendment Rules of 2020, bring all medical devices in India under regulation as drugs. Prior to this amendment, only 37 classes of medical devices were strictly regulated by the regulatory bodies, and changes in the Indian law caused amends to include all medical devices, and the Indian law that governs quality and safety of medical devices will now apply to all medical devices, effective April 1, 2020 [4] . Under the 'Productions Linked Incentives Scheme for Medical Devices, 2020' scheme, the government provides incentive at the rate of 5% of incremental sales on the initial year 2019-20, which will be applicable to the segments of medical devices identified under the categories such as radiotherapy and cancer care products, Anaesthetics & Cardio-Respiratory medical devices and Imaging medical devices (both ionizing & non-ionizing radiation products) and Nuclear Imaging Devices. Aimed at reducing the manufacturing cost of medical devices and equipment produced in the country, there was funding for 'Medical Devices Parks' in the country, 2020. They work by financing infrastructure facilities in 4 medical device parks with financial aid and grants of Rs. 400 crores, with the maximum aid being Rs.100 crore to each located intricately across the country in major central hubs [4] . This question intends to investigate the awareness about these initiatives among the people related to this sector. It has been observed in Chart 7 and Fig 3, the majority of the respondents are unaware of the initiatives taken by the Government of India in 2020. On average, only about 9-15% of respondents are aware of each of these initiatives, and 40% of respondents know about all the government initiatives taken to boost up the medical device industry. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Have you heard of any of the following initiatives from GoI? All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. The frequency characteristics of a) The medical devices amendment rules of 2020 that bring all medical devices in India under regulation as drugs b) A production linked incentives scheme for medical devices, 2020 c) Funding for medical devices parks in the country, 2020 d) All of the above e) None of the above estimated from the respondents' data. 2020 was the year of COVID-19 when a lot of small indigenous biomedical device manufacturers had risen to the occasion and helped in handling the pandemic. To support them, the government has put them under regulations (like drugs) and, on the other hand, gave this industry some benefits through some initiatives. But there was not enough dissemination of knowledge/awareness about these initiatives. Unless the awareness increases, it will not give enough boost to the medical devices manufacturing sector. The question was intended to get the respondents' view (who are aware of the Biomedical Devices From Chart 8 and Table 5 , we observe that a whopping 94% (majority) of respondents believe that such a regulatory authority is needed to control the Indian medical devices manufacturing industry. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Do you feel that unlike the America (FDA) or the Europe (EU), India lacks a high standard licensing authority for regulation? All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; This is a positive sign that many respondents are aware of our current regulatory bodies' shortcomings and limitations and the strict implementation of their standards. Thus, people see a reason for bringing about change and implementing a higher standard licensing authority as the Food and Drugs Administration (FDA) or European Medicines Agency (EMA). We also tried to investigate the ways to improve the quality management (ISO 13485) and the endurance testing (ISO 10651) implementation on medical devices in the Indian biomedical sector. The main intention was to understand the perception of the respondents on the proposed solutions to enhance the quality management system and the endurance testing of the medical devices manufactured in India. ISO 13485 is a standard related to the quality management system (QMS). The current version of this guideline is ISO 13485:2016 specifies requirements for QMS where an organization needs to showcase its ability to offer medical devices and related services that consistently meet client and applicable regulatory conditions. ISO 13485 is based on the ISO 9001 Process model concepts of Plan, Do, Check, Act intended for regulatory compliance. Participation of such organizations can be at any phase of the life cycle, which comprises production, installation, design, and development or servicing of a medical device and design development or provision of related activities (for example, technical support). This standard is also usable by suppliers or external parties that provide products, including QMS related services to such organizations [16] [17] . ISO 13485 certification mainly helps to improve overall performance, increase market reach & exclude unreliability. It helps to achieve the following objectives: • Increase efficiency cut monitor performance and cost • Outline how to review the processes • Meet regulatory conditions and customers' expectations • Demonstrate that you produce safer medical devices The main classic feature of this standard is its applicability to organizations, irrespective of their type and size, except where clearly stated. If applicable regulatory requirements permit leaving out of designing & development protocols, which can be used to explain their exclusion from QMS. These can All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint be served as alternative tactics that can be addressed to QMS. It is the important responsibility of the organization to make sure that claims of conformity to this standard reflect any exclusion of design and development controls [16] [17] . ISO 10651 consists of six parts, under the general title Lung ventilators for medical use -Particular requirements for basic safety and essential performance. These parts of ISO 10651 specify the basic safety and essential performance requirements for gas-powered emergency resuscitators planned for use with humans by first responders. This equipment is intended for emergency field use and is planned to be continuously operator attended in everyday use [18] . To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.802, providing us the way for further data analysis (alpha value-0.6-1 is reliable). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint As already discussed, stringent laws and their implementation lack from the government's side, which results in poor manufacturing of medical devices. 51.6% of respondents agreed that the implementation of strong and strict laws might improve quality management and endurance testing, making it the superior solution from all the other possible solutions. Also, a skilled workforce (by taking into account poor literacy rate and less availability of biomedical device industry personnel) is essential in every case, whether to improve the manufacturing or to enhance the quality testing in the Indian medical devices industry. For the same, 42.1% of respondents strongly agreed that skilled personnel recruitment might improve the quality management and the endurance testing of the medical devices manufactured in India. Also, 40.2% of respondents strongly agreed that the government should uplift the indigenous medical device sector by offering fundings and appropriate testing facilities (considered based on the availability of money and the damaged ecosystem infrastructure, for raising money on their own for qualitative checking of devices providing the facility for the same). A strong certification body (by taking into account the 'Aatmanirbhar' movement of India and thinking of setting standards for our own country which can be accepted worldwide. This can increase both ease All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint of implementation and market opportunities for native organizations) should be present to avoid the production of ineffective, hazardous medical devices, to improve consumer protection, eliminating trading of below standard devices, etc. Thus, the establishment of the same might improve the quality and the endurance testing of Indian medical devices, as strongly agreed by 35.1% of respondents. Overall results (Chart 9) demonstrated a need to improve the quality management and endurance testing for the implementations in the medical device sector, and most of the respondents agreed with the proposed solutions. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The requirements of this standard are applicable to all phases of the life cycle of medical devices. The process explained in this standard appropriate to risks associated with a medical device, for example, risks linked with biocompatibility, radiation, electricity, data & systems security, moving parts, and usability. This process also can be applied to products, not essentially medical devices in some conditions, and can also be used by others concerned with the overall medical device life cycle [19] . The question intends to define the possible ways to improve the risk management implementation of biomedical devices. To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.789, providing us the way for further data analysis (alpha value-0.6-1 is reliable). The frequency characteristics of each of the probable solutions to strengthen the quality management system and the endurance testing are described in Fig 6 and Fig 7. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint 46.5% of respondents agreed that safety testing and implementation of strict regulations might improve the risk management system of medical devices manufactured in India. The post-production analysis consists of four sections: a) to set up a system to assemble and review appropriate production and post-production data b) to gather relevant data for the medical device under examination c) review if the information is appropriate to the medical device safety d) if any of the aforementioned situations take place, the manufacturer needs to take measures [20] . 39.9% of respondents strongly agreed that post-production analysis is obligatory to enhance the risk management system. A risk management plan is a record that a project manager develops to anticipate risks, evaluate impacts, and determine responses to risks. The plan consists of identifying risk, assessing risk, a potential treatment of risk, creating strategy, implementing, reviewing, and evaluating the plan [21] . 36.1% of respondents agreed that developing a proper risk management plan might avoid manufacturing faulty and sub-standard medical devices. Designing clinical studies for medical device validation requires expertees for better productive results. Thus, lack of a skilled workforce and deficiency of adequate knowledge are among the major causes for All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint the failure of the risk management system. Therefore, 40.8% of respondents strongly agreed that the recruitment of professional, knowledgeable expertees might improve the risk management system leading to the manufacturing of useful medical devices. Overall results (Chart 10) proved that risk management should be improved, and the respondents also agreed on the possible solutions that can be implemented to improve this risk management on medical devices. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. There are some difficulties that the Indian medical device industry is confronting, like regulatory/legal issues, unfavorable duty structure for both imports and exports, establishing affordable products, rising labor productivity skills, elevated capital cost, and consent delays [22] . Compared to others, like the US and the EU, the concerns in India vary explicitly in areas such as design systematization/localization of devices, regulatory standards to meet the original equipment manufacturer brand, in-country production, and dissemination. The question was intended to find out the perception of respondents on the major cause of limitations faced by the medical devices sector. To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.746, providing us the way for further data analysis (alpha value-0.6-1 is reliable). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Currently, imported raw substance consumers in an extent of manufacturing industries segment are in a place due to inverted customs duty structure that leads them non-competitive against inexpensive finished product imports and deters domestic value addition. Under the 'inverted duty structure,' import duty on accomplished products is lesser than on parts or elements used in producing the components [23] . And, 55.7% of respondents agreed to the unfavorable duty structure to be the primary cause for the limitations faced by the Indian medical devices industry. To manufacture a safe, effective, economical device, the recruitment of skilled personnel is obligatory. In most cases, due to the deficiency of qualified personnel, the quality of finished products is below average compared to foreign products. 42.7% of respondents agreed with the same for the significant cause of hindrance of advancement in the Indian medical devices industry. To diminish input costs of manufacturing goods, there is a necessity for the Government to offer infrastructure, logistic assistance that will empower manufacturers to diminish the cost of inputs and also provide economical products. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint Through its headlight, the Govt. of India 'Make in India' inaugural counted heavily on the Indian manufacturers to encounter the uprising requirement of essential healthcare equipment for India, pressing the Indian medical devices industry to turn into self-reliant or Atmanirbhar Bharat. At this time, when India rushes to become Atmanirbhar, the medical device industry seeks Government endorsement in terms of various policy initiatives to establish an enabling ecological system for the native medical device industry to understand its capability. And, 36.7% of respondents strongly agreed that the government has not focused on the upliftment of the Indian biomedical sector. The government should also bring some changes in their old policies, laws, and regulations to promote the manufacture of useful indigenous medical devices. Due to the lack of standard laws and regulations, medical devices of sub-standard quality are produced, decreasing their demand. 35.8% of respondents strongly agree on the same. Due to the production of sub-standard products, the domestic demand also decreases, and the export of foreign products increases. Thus, to enhance the domestic demand, there is a need to build trust in Indians and outsiders that the products manufactured are safe, effective, and cheap. 38% of respondents majorly stayed neutral/ in confusion regarding the same as a cause for the limitations of the Indian medical device industry, and 25.6% of respondents agreed to it as the least cause for the same. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. As we had already discussed the causes of limitations of the Indian medical devices industry, we then tried to understand the perception of the respondents regarding the approaches/measures to be taken to overcome those limitations, as proposed by us. The question intends to find out how the limitations that are being faced by the industry can be improved. To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.795, providing us the way for further data analysis (alpha value-0.6-1 is reliable). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Increasing skilled workforce c) Implementation of strong laws and regulations to improve quality standards estimated from the respondents' data. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint As discussed earlier, inverted duty structures are majorly responsible for the cause of limitations of the Indian medical device sector [23] . And, to overcome the same limitation, there is a need to reduce the imposed tax rate on domestic manufacturers. 47.5% of respondents agreed with the same as the superior probable solution to advance the Indian medical devices sector. Investors also play a significant role in the betterment of the Indian medical devices industry. Due to the lack of quality products from the same, the investors hesitate to invest money to produce medical devices, as they fear going into a loss. Thus, gaining the trust of investors is essential to improve the medical devices industry. 38.6% of respondents resonated and agreed with the same to overcome the limitation of the Indian medical devices sector. The results proved that, yes, there is a lot of scope for improvement in the Indian medical devices industry. The respondents also agreed on the possible ways which can be taken to improve the conditions. Chart 12 discusses the percentage of responses calculated for each possible approach to curb the limitations of the Indian medical devices industry. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Industry-Academia gap! Yes, there is. It's the gap between the engineering education system and the industry's expectations from the entry-level students. And, something is lacking from both sides. We had a practical overview of the same debate, which made our motive to prepare the question to understand the knowledge and the perception of the respondents concerning the Industry-Academia gap. According to Chart 13, 98.41% of respondents echoed a gap between industry and academia, causing a hold in the advancement of medical devices in India. Table 10 demonstrates the frequency characteristics estimated from the respondents' data. The results proved that there is a need to do some work to close the gap between industry and academia. Chart 13. The percentage of respondents agreed and disagreed on the gap present between industry and academia. 98.41% Is there any gap between Industry and Academia? All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. But the question still remains, how to bridge the gap between academia and industry. Thus, we proposed the best solutions for the same and tried to understand the perception of the respondents. The question intended to find out the possible solutions to improve the relationship between the industry and academia. To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.816, providing us the way for further data analysis (alpha value-0.6-1 is reliable). The frequency characteristics of each possible solution to bridge the relationship between industry and academia are discussed in Fig 12 and Fig 13. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint Chart 14 describes the percentage of responses for each probable solution to better the relationship between industry and academia. Be it any proficiency, encouraging students play a very significant role. Every student's uniqueness and strength lie in diverse areas. The pharma and biomedical students should be provided with opportunities to explore/discover their potential. Out-of-the-box work by the students could offer them strong enthusiasm. On the other hand, the budding researchers should not be demotivated in any cases, leading to the destruction of creativity and moral confidence. And, the respondents also resonated with the same vision of performing out-of-the-box work like preparing prototypes. 42.1% and 37.7% of respondents have agreed and strongly agreed with pitching the prototype's ideas to the industry, respectively. The syllabus of the pharma/biomedical engineering colleges is now a highly debated topic. According to various dignified persons, the syllabus should be discarded and prepared on the latest trending topics. Thus, a balanced syllabus should be provided, for example, a section for fundamental courses and another section for advanced courses, which would build their knowledge on the trending topics. The students should also be provided with hands-on exercises, assignments, projects for the preparation of devices. This would make the foundation base for the students, and they would be easily recruited by the industry. 48.4% of respondents have strongly agreed to the same. College students are generally not conscious of real workplace expectations. Hence cognizance is to be created by revealing the real-time workplace to them. Internships/Industrial visits can undoubtedly connect the gap between academia and industry. Through this, the students not only discover in terms of their employment outlook but also find out about other behavioral elements. These behavioral features encompass oral communication with colleagues, seniors, and boss, learning to adapt and complete the given work, providing quality yield and learning on relevant duties. Attending common activities like teammeeting, offsite-workshops can construct a big visualization of how a company works. 44.9% of respondents have agreed to the same. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The diffusion of knowledge is a significant way to improve the relationship between academia and industry. The highly qualified academicians and industrialists should be invited for a guest talk or a lecture in the universities to promote and diffuse advanced knowledge regarding the preparation, regulation of medical devices. Their main intention should lie in building a healthy relationship between academia and industry to advance the Indian medical devices industry. 34.8% of respondents agreed to our proposed solution. Another significant solution to bridge the gap between Industry-Academia is the collaboration system. Either the industry or the government can offer the fundings to scale up the proposed prototype prepared by the academicians. As the universities majorly lack funds, their innovations do not get converted into products. Thus, the collaboration will play a major factor in scaling up the lab-scale product. 38% of respondents agreed to our proposed solution. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. strongly disagree disagree neutral agree strongly agree Every person knows that they are put on mechanical ventilators whenever a patient goes under difficult breathing conditions. But, we suspected that there might be significantly low awareness among the Indian people about the Indian companies that manufacture ventilators. The main motive was to determine the percentage of awareness about the Indian companies who manufacture ventilators from the respondents. Some options like a company providing reagents or instrumentation to the biomedical industry and belonging to the bio-informatics category and the name of the hospital were also included to check the understanding. The frequency characteristics calculated from the respondents' data for each standard medical devices company are discussed in Fig 14 . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Observing Chart 15, we conclude that, on average, 53.87% of respondents accurately identified Indian ventilator manufacturing companies (Skanray and AgVa Healthcare). About 53.54% of respondents incorrectly determined bioinformatics and reagent supplier company, Imperial Life Sciences as a ventilator manufacturing company. For the other option, which is a hospital, Wockhardt, people were more aware, and 73% of respondents identified it as a non-manufacturing ventilator company. At the same time, approximately 12% of respondents found the options doubtful and haven't voted for any. From our inspection, we actually determined right about the less awareness about the same. The overall result of the survey showed around half of the respondents correctly identified ventilator manufacturing companies. Still, a majority of respondents have mistaken a bioinformatics company for a ventilator manufacturing company. Respondents are aware that the hospital doesn't serve as a ventilator manufacturing unit, which is good. While there is only a minor percentage of people, who didn't find any options right and haven't selected any. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint The SARS-CoV-2 pandemic has changed the entire health scenario of the world [24] . The major device that came into the limelight is ventilators, required to provide oxygen to the COVID-19 affected patients. As the number of patients is increasing at an unparalleled pace, there seems to be a scarcity of providing ventilators to each patient. India is completely dependant on foreign countries regarding the ventilators. Under these circumstances, the Indian companies started mass production of ventilators, which came into the market without proper regulatory inspection and safety standards. Thus, it's a major issue that should NGOs). In a letter dated 19 th June, doctors highlighted that AgVa ventilators were not supplying 100% oxygen to COVID-19 patients and that oxygen didn't increase to the desired level [25] . Two employees of AgVa healthcare revealed that the company had manipulated to show that devices were pumping more oxygen into patients' lungs than they were [26] . A Rajkot-based private company, Jyoti CNC, has developed a ventilator named Dhaman in just 10 days, having a manufacturing cost of less than 1lakh. The ventilators were installed just after testing on one patient, and also, the installed ventilators didn't have a DCGI license. So far, 900 ventilators were installed in the state, while 230 of them were present in Ahmedabad's Civil Hospital [27] . A similar case was reported in the case of Andhra Pradesh MedTech Zone(AMTZ). Jyoti CNC automation and AMTZ have received about Rs. 22.5 crore payment from PM cares funds, but failed to produce good quality ventilators and later dropped from the ministry list. The question was intended to check the knowledge of respondents on the inefficient working of ventilator cases that emerged during the pandemic [28]. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; It was observed that 92.6% of Indians are aware of the fact that current failure cases of ventilators were reported in India. Only about 7% of people are unaware of this situation, which was not expected. It was expected that people would be significantly aware of the current scenario of the ventilators in India. Respondents are mostly aware of the ineffective working of newly produced ventilators, which correlates with our hypothesis for the particular question. The question doesn't confirm that the people have exact knowledge about the problem, but it surely confirms they might have an idea about this condition. The SARS-CoV-2 outbreak has pointed out several loopholes in the healthcare and biomedical industry. One of them is the lack of proper regulations and policies for manufacturing safe, economical, and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint effective biomedical devices like ventilators. The question was intended to correlate our possible solutions for making the manufacturing process of ventilators as smooth as possible. In the COVID-19 era, many countries have used various strategies for making the ventilator manufacture process as easy as possible. A few of them were suggested in this question as follows. Compulsory Licensing (CL) policy is an intervention mechanism that allows the government to achieve two different objectives at once; one is rewarding patentees for their invention while the other is making the patented products available to the third party in an emergency crisis like COVID-19. This policy is adopted by some countries like Canada for increasing the availability of the patented products and giving other manufacturing companies rights to construct, use, and sell the patented invention whenever necessary [29] . For the COVID-19 outbreak, USFDA took one initiative known as 'Open sourcing and ventilator software and design.' The scheme made ventilator designs and software publicly available and allowed other companies to do the modifications up to certain limits for increasing the functionality of ventilators [30] . Initially, there was no specific standard available for ventilators, but after the COVID-19 outbreak, the government issued separate guidelines for it and made consistent changes as required. Because of the constant varying Indian standards, local companies face difficulties while designing parts of the ventilators and getting approval for the final product. In this crisis, many industry personnel doesn't have much knowledge about developing new ventilators or don't have an understanding of the whole manufacturing process. So, the addition of a particular course regarding this topic may play an important role in increasing literacy about the ventilator industry. To determine the reliability of data, we performed the Cronbach Alpha test, which resulted in a coefficient of alpha of 0.817, providing us the way for further data analysis (alpha value-0.6-1 is reliable). Table 12 demonstrates the values of central tendency calculated from the data of the respondents. And, all the respondents agreed to all the solutions as interpreted from mean values. The frequency characteristics of each of the policies adopted to manufacture ventilators in India with ease are discussed in Fig 16 and Fig 17. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint Despairing hospitals state that they can't find anywhere to purchase the ventilators, which assist patients in breathing and those at death's door due to COVID-19. The number of imported ventilators and manufactured ventilators didn't cope up as the COVID-19 cases started mounting. India, which was primarily dependent on foreign ventilators, was trapped in a hole. The export system got closed, and very few Indian medical companies manufacture ventilators at an economical and complying safety standard. The background of our question stands on the same. The motive behind our question was intended to investigate the reason behind the less production of ventilators in India. To check the reliability of the data, we performed a Cronbach alpha test that gave a coefficient of alpha .800 (alpha value-.6-1 reliable), flooring our way for further analysis of the collected survey data. Table 13 depicts the values of central tendency estimated from the respondents' data. And, all the respondents agreed to all the reasons for less production of ventilators as interpreted from mean values. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint strongly disagree disagree neutral agree strongly agree In the survey, it was observed (Chart 17) that about 44% of respondents strongly agreed with the opinion that the lack of skilled personnel might be the primary reason behind less production of ventilators. Approximately 51% of respondents agreed with 'Companies/Investors are not interested,' which may be the primary reason, while about 41% of respondents said that the secondary reason is 'As the doctors don't trust Indian branded devices.' About 37 % of respondents agreed with dependency on importing the ventilators as a reason for the mentioned issue, but this option may have the least effect compared to the other three. Till COVID-19 emerged, the ventilator industry hasn't got much serious attention from investors. Also, India was initially dependent on countries like China, the USA, etc., for the import of raw materials of ventilators or its complete assembly. The number of companies who manufacture ventilators was also very few at the start; hence there was a lack of skilled people to initiate rapid production of ventilators. The doctors also mainly don't trust Indian branded devices and prefer the imported ones because of their high performance and other standard quality attributes. The overall outcome of these reasons was nothing but the low production of the ventilator device. This question was designed to determine the major root cause of less production of ventilators based on respondents' opinions. The survey results showed that the respondents feel that lack of Industry personnel is the important cause behind this issue. While they also think that least companies'/investors' interest and doctors' distrust of the Indian brands are possible reasons for less production. A small portion of people believe dependency on imports is also the cause of the mentioned issue, but it has less significance than other mentioned options. However, it again proved that people are less aware of the fact that ventilators are majorly exported from foreign countries. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint Pulmonary barotrauma, a complication of mechanical ventilation, is the presence of extra alveolar air in locations where it is not present under normal circumstances. The patients on mechanical ventilation ventilate with positive pressures, in contrast to the natural mechanism of breathing in humans, which depends on negative intrathoracic pressures. This may elevate the trans-alveolar pressure or the difference in pressure between the alveolar pressure and the pressure in the interstitial space, resulting in leakage of air into the extra-alveolar tissue. Barotrauma is most commonly due to alveolar rupture, which leads to an accumulation of air in extra alveolar locations. Excess alveolar air could then result in complications such as pneumothorax, pneumomediastinum, and subcutaneous emphysema. The incidence of barotrauma in patients receiving invasive mechanical ventilation is much higher than patients receiving non-invasive mechanical ventilation. Patients at increased risk of developing barotrauma from mechanical ventilation include individuals with predisposing lung pathology such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease (ILD), and acute respiratory distress syndrome (ARDS). However, certain ventilator settings, as well as specific disease processes, may increase the risk of barotrauma significantly. When managing a ventilator, physicians and other health care professionals must be aware of these risks to avoid barotrauma [13] . The intention for preparing this question was to determine the respondents' perception of the possible soultions of Barotrauma proposed as in the options. The coefficient of alpha value .719 denoted high reliability of data (from Cronbach's alpha test), making it suitable for further analysis. Table 14 demonstrates the values of central tendency calculated from the respondents' data, where the respondents agreed to all options determined from mean values. The frequency characteristics for each of the possible preventive measures of Barotrauma estimated from the respondents' data are discussed in Fig 20 and Fig 21. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Also, 44% of respondents agreed to control the pressure manually in the ventilator. The survey participants also echoed that adjustment of proper pressure regulation according to the patient's requirement is necessary to avoid the development of extra pressure leading to any complications. Artificial intelligence (AI) has currently grasped the healthcare market with its exceptional capabilities to treat diseases. Thus, applying the AI (pressure sensors) could sense the patient's pressure, and the ventilator could be adjusted according to it. This diminishes the chances of developing any extra pressure, which might be detrimental to the patient's health. Though the AI system has not still disseminated in a broad population, an average of 34.56% (agreed and strongly agreed) respondents considered it as one of the possible solutions for the same. Patients with predisposing lung pathology such as COPD, asthma, ILD, and ARDS are at high risk of developing barotrauma. Treatment of these ailments can reduce the chances of developing barotrauma, thus preventing alveolar rupture [13] . 36.1% of respondents confirmed this as one of the possible solutions for the same. Thus, we observed that many respondents have agreed with all four solutions (with a very less significant difference), and very few people have strongly disagreed with all four possibilities (on an average 6.3%). Ventilator-associated pneumonia (VAP) remains a feared complication in ICU and high postoperative surgical patients. VAP is associated with substantial excess morbidity. On average, 10-20% of ICU patients ventilated for less than 2 days experience VAP. VAP prevention targets the primary pathogenic mechanism, which is bacterial translocation from the stomach and oropharynx to the lower respiratory tract. Within All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; hours following endotracheal intubation, pathogenic microorganisms colonize the oropharyngeal mucosal surfaces, dental plaque, sinuses, and stomach. Accumulation of oropharyngeal secretions colonized with these pathogens occurs above the endotracheal tube (ETT) cuff. Generally, VAP prevention focuses on reducing the exposure time, maintaining oral hygiene by antiseptic rinsing, and avoiding microaspiration [13] . The main motive behind the question was to understand the perception of the respondents on the proposed solutions for treating VAP. The Cronbach alpha test resulted in a coefficient of alpha .849, which considered the data highly reliable. Further analysis was carried out with the collected data to find out the observation of the respondents. The frequency characteristics of each of the probable preventive approaches for treating VAP calculated from the respondents' data are discussed in Fig 22 and Fig 23. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Broad-spectrum intravenous antibiotics and nebulized antibiotics could represent an attractive alternative for VAP treatment, mainly for cases caused by MDR Gram-negative bacteria and other classes. As MDR pathogens are only gullible to traditional antibiotics associated with adverse effects, nebulized therapy is specifically symbolized as a fascinating approach for VAP treatment [32] , [33] . According to the collected data (Chart 19) , 47.5 % of the respondents agreed with the same and made it the superior solution for the treatment. Antibiotics for treating lower respiratory tract infections are not always effective and can result in increased antibiotic resistance. Prophylactic approaches by altering the surface of ETTs to prevent the growth and establishment of bacteria have exhibited promising results. Besides, surface modifications with bacteriostatic properties or active coatings that possess a bactericidal effect have been proven effective [34] . VAP can occur through impairment of cough and mucociliary clearance, accumulation above and leaking around the cuff of contaminated secretions, or increased bacterial binding to the surface of the bronchial epithelium. With non-invasive positive pressure ventilation, the risk of aspiration of colonized or infected oropharyngeal secretions is likely to be reduced, which is experimentally proven [35] . Of the above two proposed solutions, on average, 41.86% of respondents agreed to them as the probable solution for the treatment of VAP. The primary routes of bacterial entry into the lower respiratory tract are the aspiration of oropharyngeal pathogens and leakage of subglottic secretions containing bacteria around the endotracheal tube cuff. Subglottic secretion drainage (SSD), using a specially designed endotracheal tube with a separate dorsal lumen that opens immediately above the endotracheal cuff, has been developed to prevent the occurrence of VAP [36] . 33.5% and 24.4% of respondents agreed and strongly agreed to subglottic secretion drainage as the possible solution for the same, respectively. Daily weaning trials and sedation holidays are validated as strategies that limit the time of mechanical ventilation. As the risk of VAP is related to the duration of mechanical ventilation, limiting this duration All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint makes physiologic sense with regards to reduction in VAP rates [37] . 40.5% of respondents have agreed this strategy to be beneficial for the same. Long-term ventilation leads to an increased risk of mechanical complications, such as tube disconnection, mucus impaction, laryngeal and tracheal ulcers, and increased rates of VAP [38] . This can be prevented by early tracheostomy, and 38.3% of respondents also agreed to the same. It has been suggested that placing critically ill ventilated patients in a semi-recumbent position reduces the incidence of developing VAP. Elevating the head of the bed to 45° solves the problem [39] . On average, 35 .1% of respondents resonated the same for the treatment of VAP. Thus, we observed that many respondents have agreed with all the solutions, and very few people have strongly disagreed with all the four possibilities (8.90% of respondents strongly disagreed). Microaspiration of subglottic secretions through channels formed by folds in high-volume low-pressure cuffs of endotracheal tubes is considered an important pathogenic mechanism of VAP. A series of preventive measures target the avoidance of microaspiration. Accumulation of oropharyngeal secretions colonized with the pathogens occurs above the endotracheal tube cuff. Microaspiration of these subglottic secretions might occur through an underinflated tracheal cuff or through longitudinal folds in high volumelow pressure cuffs. Furthermore, a nasogastric tube may facilitate gastroesophageal reflux. Therefore, gastric juice may be aspirated into the lungs, provoking local inflammation. An analogous conclusion can be made regarding taper-shaped cuffs compared with classic barrel-shaped cuffs. The clinical usefulness of endotracheal tubes developed for subglottic secretions drainage is established in multiple studies and confirmed by meta-analysis. Any change in cuff design will fail to prevent microaspiration if the cuff is insufficiently inflated. Gel lubrication of the cuff before intubation temporarily hampers microaspiration through sludging the channels formed by folds in high volume-low pressure cuffs [12] . The question's primary motion was to check if the respondents resonated the same for the proposed solution to treat microaspiration. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The coefficient of alpha .848 calculated from the Cronbach alpha test proved the collected data to be highly reliable, paving the way for further data analysis. Table 16 discusses the measures of central tendency estimated from the respondents' data. All the respondents agreed with all the preventive measures, as interpreted from mean values. The frequency characteristics for each of the preventive measures to treat microaspiration calculated from the respondents' data are discussed in Fig 24 and Fig 25. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The gas contained within the cuff is redistributed from the distal to the proximal cuff end as the air pressure rises, resulting in a cone-shaped cuff in which the intra-cuff pressure is temporarily (during the inspiratory phase) higher than the cuff pressure during the expiratory phase. Also, positive pressure ventilation creates a 'self-sealing' effect by which tracheal occlusion is maintained despite airway pressure exceeding intracuff pressures. Therefore, it was hypothesized that PEEP could result in a better sealing capacity throughout the ventilation cycle and reduce micro-aspiration [40] . And, from the collected data (Chart 20), 46.2% of respondents agreed to it as the superior solution for treating the same. Conventional ETTs have a cylindrical-shaped cuff. An ETT with a taper-shaped cuff was developed for the treatment of microaspiration. Because of its tapered shape, this cuff seals the trachea, at least at one point, without fold formation [41] . This also prevents fluid leakage, thus reduces microaspiration. 39.2% of respondents agreed with the same and echoed our proposed solution. Likely, 39.9% of respondents agreed to gel lubrication of cuff prior to intubation as one of the strategies done to smoothen the procedure. Yet, by doing so, the channels along the cuff wall are plugged, thereby blocking microaspiration of oropharyngeal secretions [42] . ETTs for SSD can drain secretions through a separate dorsal lumen that opens directly above the cuff. The use of SSD was associated with a reduced ICU stay, decreased length of ventilatory dependence, and an increased time to the first episode of VAP [43] . 42.1% of respondents agreed to the same for the possible treatment of the microaspiration. Gastric overdistention has been historically considered a risk factor for VAP as it is assumed to facilitate bacterial translocation from the stomach to the respiratory tract. Monitoring gastro-intolerance to enteral feeding by checking residual volumes is a frequent practice. The most frequent thresholds used to interrupt enteral feeding are residual volumes of 200-250 mL. Yet, cessation of enteral feeding is not recommended unless residual volumes exceed 500 mL [44] . This solution has been least agreed upon when compared with others. 35 .4% of respondents agreed to it as one of the possible solutions for the same. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint 34.2% of respondents agreed to the material change of ETT, the option which has the least percentage of agreement. Recently, ultrathin polyurethane cuffs have been developed to minimize the channel size within folds of an inflated cuff. Polyurethane ETTs prevented fluid leakage more efficiently than PVC cuffs (p < 0.001). Thus, we observed that many respondents have agreed with all four solutions, and very few people have strongly disagreed with all the solutions (on an average of 9.3%). Acute respiratory distress syndrome (ARDS) is characterized by severe inflammatory response and hypoxemia. Worsening of this inflammatory response, called "ventilator-induced lung injury" (VILI), can be caused by the use of mechanical ventilation (MV) for correction of gas exchange. The process of withdrawing mechanical ventilation, referred to as weaning from MV, may cause worsening of lung injury by spontaneous ventilation. The initial evaluation and treatment of the patient with ARDS begin with the correction of the inflammatory mechanism that triggered the process and the decision to start ventilatory support, which can be provided as supplemental oxygen, high-flow nasal oxygen therapy, and non-invasive MV and in most cases invasive MV. The choice of ventilatory mode (controlled versus spontaneous) and parameter settings to adopt the "lung-protective ventilation" strategy are other essential aspects. This protective ventilation consists of the adjustment of low tidal volume based on the weight and elevated levels of Positive end-expiratory pressure (PEEP) with Respiratory regulation (RR). In the most severe cases, the use of a Neuro-muscular blockade (NMB), prone position, and Extra-corporeal membrane oxygenation (ECMO) will be evaluated when there is refractory hypoxemia. These initial strategies are the key to successfully treating ARDS and therefore weaning success and reducing MV time [14] . The significance of the question is to understand the perception of the respondents on the possible solutions presented for the treatment of ARDS. The coefficient alpha .760 estimated from the Cronbach alpha test ensured that the data obtained is reliable, opening the window for further data analysis. Table 17 depicts the values of central tendency estimated from the respondents' data. And, the respondents agreed to all the possible solutions, as interpreted from the mean values. The frequency characteristics of each of the probable measures to treat ARDS calculated from the respondents' data are discussed in Figures 26 and 27 . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint In ARDS, there is an inflamed lung with increased levels of proinflammatory mediators, and ventilation can also enhance the amount of inflammatory mediators produced by the lungs. Once the barrier function of the alveolar-capillary membrane is lost, there is leakage of mediators to the circulation (decompartmentalization), leading to multi-organ failure. The use of lung protective ventilation reduces the cyclic collapse of the lung by minimizing the inflammatory response and preserving the barrier function of the lungs [45] . From the collected data (Chart 21), 44.6% of respondents agreed with this solution, mostly for the treatment of ARDS. NMB agents are considered beneficial as one of the preventive measures for ventilator-induced lung injury. By resting the respiratory muscles, NMBA can avoid high regional transpulmonary pressures and induce less regional volutrauma or biotrauma. The use of NMBA can also avoid dangerous respiratory entrainment ("reverse-triggered" breaths) and pendelluft phenomena [46] . The same solution has been agreed by 38.6% of respondents for preventing ARDS. Prone-positioning (PP) maintains a safe gaseous exchange. In PP, the transpulmonary pressure and ventilation are more homogeneously distributed throughout the lungs. Overall, lung stress and overdistension are minimized, lung volume increases, and biotrauma and ventilator-induced lung injury are decreased by PP [46] . 36.4% of respondents agreed with this technique as a possible treatment for ARDS. Ventilator asynchrony is associated with increased ICU stay and mortality. Episodes of asynchrony may occur, worsening hypoxemia and increased respiratory muscle work. Asynchrony may cause large transpulmonary pressure swings that may be especially harmful in critically ill patients receiving lungprotective ventilation. The presence of asynchrony during the weaning of ARDS patients from MV could be better quantified and distinguished. The presence of asynchrony, both quantity, and type, could be considered a predictor of MV weaning failure in patients with ARDS [14] . 35 .4% of respondents agreed to monitor asynchrony for the treatment of ARDS, making it the least agreed from all the other possible solutions. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21251720 doi: medRxiv preprint Thus, we observed that the maximum number of respondents have agreed with all the solutions, and very few people have strongly disagreed with all of them (on an average of 4.5%). This research-based survey was done to grasp the current scenario, the strength, and shortcomings of the Indian medical device industry. The survey was also conducted to uncover the people's perception of the Indian medical device industry as well as on the problems related to ventilators. Respondents were also given details of the problems related to the Indian biomedical industry/ventilators and asked to rate the best possible solutions that we came up with for the problems. The survey questionnaire was prepared according to the best of our ability to understand the same aforementioned purpose. And it definitely gave an indication of many problems and supported our proposed solutions. 315 respondents took part in this survey ranging from graduates to Ph. D students. The first section of the survey consisted of the problems and solutions related to the biomedical industry of India. Many people agreed with the reasons due to which this industry is facing obstacles and also agreed with our proposed solutions that can be taken into account to make this industry better. The second section was based on one of the biomedical devices, i.e., ventilators, as it was one of the top requirements in this era of COVID-19. The frequent use of ventilators resulted in various pharmacological issues, which we tried to address through this survey. We have also tried to explore the main reasons for less production of ventilators and proposed groundbreaking solutions for the conditions associated with frequent use of ventilators. The results complied with our hypothesis as the majority of the respondents have agreed with almost all the probable solutions in both the sections given by us as options. India is a ground full of potential for parties in the medical devices industry. The country has also turned into one of the principal addresses for high-end diagnostic facilities with enormous capital investment for progressive diagnostic equipment, thus providing an increased proportion of the population. Moreover, Indian medical service customers have become more mindful of their healthcare maintenance. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. Covid-19 -a pandemic {\&} a policy driver to healthcare system in India A special report on India's biotech scenario: Advancement in biopharmaceutical and health care sectors Balancing growth and innovation in Indian biotech firms Influence of financial and policy environments on the business strategy of biotechnology companies in India The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: An interview-based study Biotechnology industry in India: Opportunities or challenges Biotech science, biotech business: current challenges and future prospects Lung ventilators and related equipment -Vocabulary and semantics Coronavirus: What are ventilators and why are they important? -BBC News Helping India Breathe How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients Barotrauma And Mechanical Ventilation Weaning from Mechanical Ventilation in ARDS: Aspects to Think about for Better Understanding, Evaluation, and Management WHO | Medical Device -Full Definition Quality Management System (QMS) ISO 13485 Certification | BSI America ISO -ISO 13485:2016 -Medical devices -Quality management systems -Requirements for regulatory purposes Lung ventilators for medical use -Particular requirements for basic safety and essential performance -Part 5: Gas-powered emergency resuscitators ISO -ISO 14971:2019 -Medical devices -Application of risk management to medical devices PDF) ISO 14971-Medical Device Risk Management Standard Risk management plan -Wikipedia Challenges in medical device market in India as compared to the global market -Health Files by Vimal Kumar P | ET HealthWorld Unfavourable duty structure hits Indian manufacturing' -Business News , Firstpost The SARS-CoV-2 outbreak: What we know Mumbai hospitals return 81 ventilators made by AgVa-Maruti on non-performance -cnbctv18.com AgVa Manipulated PM Cares Ventilator Software To Hide Poor Performance: Former Company Employees Allege Foul Play Behind Ahmedabad's Ventilator Controversy, a Backstory of Connections to Top BJP Leaders Coronavirus | Ventilators from firms funded by PM CARES fail trials -The Hindu WTO | intellectual property (TRIPS) -TRIPS and public health: Compulsory licensing of pharmaceuticals and TRIPS A review of open source ventilators for COVID-19 and future pandemics Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults -UpToDate Nebulized antibiotics for ventilator-associated pneumonia: A systematic review and metaanalysis The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: A systematic review No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Antimicrobial polymer modifications to reduce microbial bioburden on endotracheal tubes and ventilator associated pneumonia Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia. A prospective epidemiological survey from a single ICU Intermittent subglottic secretion drainage and ventilator-associated pneumonia: A multicenter trial Prevention of ventilator-associated pneumonia in the intensive care unit: A review of the clinically relevant recent advancements Early tracheostomy decreases ventilation time but has no impact on mortality of intensive care patients: a randomized study Reducing the risk of ventilator-acquired pneumonia through head of bed elevation High level positive end expiratory pressure (PEEP) in acute respiratory insufficiency Effect of tracheal tube cuff shape on fluid leakage across the cuff: An in vitro study Gel lubrication of the tracheal tube cuff reduces pulmonary aspiration Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia Ventilator-Associated Pneumonia and Role of Nurses in Its Prevention -PubMed Lung protective ventilation in ARDS: The open lung maneuver Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity The authors would like to thank Dr. Ramesh Parameswaran and Dr. Vignesh Muthuvijayan for their valuable support in conducting the survey. Author SP would like to thank the Indian Institute of The Indian healthcare sector is much multifarious and full of possibilities in every fragment, including suppliers, payers, and medical technology. With the rise in rivalry, businesses are sounding to investigate the latest dynamics and trends that will have an optimistic strike on their business. The whole research was primarily aimed at finding out about the Indian biomedical device industry's current scenario. Although the Indian biomedical industry is one of the steadily growing markets with many potentials, there are still some loopholes present, like the absence of strong laws and authority. Not only this, but many underlying problems are associated with it. With this research-based survey, we aimed to bring about the matter to the hands of the people, mostly from the pharmacy/biomedical field, to understand the same. We tried our best to distribute this paper to a mass of people to be considered a problem and could be worked upon. Moreover, we had worked upon ventilators in India and the possible reasons for ventilators being scarce at the most important time, i.e., Coronavirus. We came up with possible changes that can be done to remove the current problems associated with the ventilators, like barotrauma, Ventilator-Associated Pneumonia (VAP), microaspiration, and ARDS. We desired to bring light upon this topic to bring it out to the masses and the probable solutions for it so that ventilators can be made better.This research survey provides the in-detailed condition of the Indian biomedical industry as well as the ventilators, consisting of the perception of Indian respondents on our proposed solutions. The authors declare no conflict of interest.